PERKINS CAPITAL MANAGEMENT INC - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 34 filers reported holding CANCER GENETICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PERKINS CAPITAL MANAGEMENT INC ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2019$4,000
-99.2%
35,000
-98.8%
0.00%
-99.1%
Q2 2019$487,000
-35.3%
2,983,778
-4.9%
0.34%
-31.2%
Q1 2019$753,000
+645.5%
3,136,528
+649.9%
0.50%
+535.9%
Q4 2018$101,000
-92.5%
418,250
-67.5%
0.08%
-90.3%
Q3 2018$1,339,000
+49.8%
1,287,250
+28.1%
0.80%
+25.6%
Q2 2018$894,000
-43.8%
1,004,550
+4.2%
0.64%
-55.3%
Q1 2018$1,590,000
-13.2%
963,600
-2.6%
1.43%
-18.7%
Q4 2017$1,831,000
-15.9%
989,700
+22.7%
1.76%
-22.8%
Q3 2017$2,178,000
-33.4%
806,700
-2.6%
2.28%
-37.1%
Q2 2017$3,272,000
-4.6%
828,366
-1.0%
3.63%
+2.5%
Q1 2017$3,431,000
+194.3%
836,908
-3.1%
3.54%
+177.0%
Q4 2016$1,166,000
-22.9%
863,600
-0.1%
1.28%
-15.5%
Q3 2016$1,513,000
+30.8%
864,600
+48.8%
1.51%
+14.1%
Q2 2016$1,157,000
+120.4%
581,200
+214.2%
1.33%
+101.8%
Q1 2016$525,000
-13.9%
184,9500.0%0.66%
+0.3%
Q4 2015$610,000
-47.5%
184,950
+140.1%
0.66%
-19.6%
Q1 2014$1,162,000
+3.1%
77,025
-5.8%
0.82%
+7.2%
Q4 2013$1,127,00081,7750.76%
Other shareholders
CANCER GENETICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 836,908$3,431,0003.54%
Fairbanks Capital Management, Inc. 233,170$956,0000.94%
DIKER MANAGEMENT LLC 63,315$260,0000.12%
EAM Investors, LLC 117,878$483,0000.08%
WEDBUSH SECURITIES INC 87,000$357,0000.05%
Acrospire Investment Management LLC 11,090$45,0000.04%
TWO SIGMA SECURITIES, LLC 16,053$66,0000.01%
THOMPSON DAVIS & CO., INC. 2,000$8,0000.01%
Manchester Capital Management LLC 9,000$37,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 40,158$165,0000.00%
View complete list of CANCER GENETICS INC shareholders